May 26, 2005 (Atlanta) — As the result of positive phase 3 trials, ropinirole (Requip) has been approved for the treatment of restless legs syndrome (RLS). The data presented here at the 2005 American ...
A recent study has identified chronic kidney disease (CKD) patients—especially those undergoing dialysis—as a group at significantly higher risk of developing Restless Legs Syndrome (RLS). The ...
Restless leg syndrome (RLS) is often worse at nighttime. Some people may only have the symptoms at this time. Many with RLS also experience limb movements during sleep. As many as 80% of people with ...
Hosted on MSN
Link between restless leg syndrome and kidney disease found in new research. Who are at risk? Check symptoms
A growing body of research has highlighted a strong association between chronic kidney disease (CKD) and Restless Legs Syndrome (RLS), a neurological condition that significantly affects sleep and ...
Restless legs syndrome (RLS) and periodic limb movements (PLMs) are increasingly recognized as risk factors for cerebrovascular and cardiovascular diseases, particularly stroke. Conversely, stroke can ...
PLEASANTON, Calif., April 19, 2023 /PRNewswire/ -- Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation ...
Restless legs syndrome (RLS) is a sleep disorder that causes a feeling of heaviness and discomfort in the legs, usually after going to bed. Stretching or moving the legs usually helps. It may also ...
Treatment of restless legs syndrome (RLS) usually involves dopamine agonists, which are approved for treatment of RLS in most countries; α-2-δ ligands, such as gabapentin enacarbil and pregabalin, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results